Who is sponsoring NCT03337880?

NCT03337880 is sponsored by Poitiers University Hospital.

What drugs are being tested in NCT03337880?

Interventions in NCT03337880: instrumental delivery.

What condition does NCT03337880 study?

NCT03337880 studies Instrumental Delivery; Nec, Affecting Fetus or Newborn.

Is NCT03337880 still recruiting?

NCT03337880 is currently completed. Last updated 29 January 2019.

Last reviewed 2019-01-29 · How we verify

NCT03337880

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neonatal Outcomes in Instrumental Delivery

Completed Last updated 29 January 2019

What this trial tests

trial testing instrumental delivery in Instrumental Delivery; Nec, Affecting Fetus or Newborn in 300 participants. Completed in 4 October 2018.

Timeline

4 December 2017

Primary endpoint
4 October 2018

4 October 2018

Quick facts

Lead sponsor	Poitiers University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	300
Start date	4 December 2017
Primary completion	4 October 2018
Estimated completion	4 October 2018
Sites	1 location across France

Drugs / interventions tested

instrumental delivery

Conditions studied

Instrumental Delivery; Nec, Affecting Fetus or Newborn — all drugs for Instrumental Delivery; Nec, Affecting Fetus or Newborn →

Sponsor

Poitiers University Hospital

Who can join

Adults 12 Hours to 72 Hours, any sex, with Instrumental Delivery; Nec, Affecting Fetus or Newborn. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the impact of instrumental delivery on newborn head mark and newborn comfort over the impact of non-instrumental delivery. It is also to evaluate how mothers age, Body Mass Index, instrumental extraction indication, extractor type, variety and height of the fetal presentation, operator, time of birth (day or night) and birth weight impact on head mark existence and newborn comfort.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Poitiers University Hospital trials

Trials by the same sponsor.

NCT07350291 — Evaluation of the Diagnostic Capabilities of Saliva Samples From Pediatric Patients, Promoting Active Involvement of the · NA · not yet recruiting
NCT07411651 — Confirmation of the Link Between Endocrine Disruptors Exposure and Breast Cancer and Identification of Biological Respon · NA · not yet recruiting
NCT07463963 — Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febr · NA · not yet recruiting
NCT07475442 — Prognostic Factors of Hospitalization for Patients Aged 75 and Over in Emergency Department in France - Monocentric Retr · not yet recruiting
NCT07412717 — The Efficacy of Combining Music Intervention With Nicotine Replacement Therapy to Reduce Smoking Craving, Among Healthca · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03337880 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Poitiers University Hospital
Last refreshed: 29 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03337880.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing